Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Shi-Xiong Liang"'
Autor:
Rui-Jun Zhang, Hong-Mei Zhou, Hai-Yan Lu, Hong-Ping Yu, Wei-Zhong Tang, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ying Long, Ting-Shi Su, Bang-De Xiang, Mei-Ling He, Xiao-Ting Wang, Shi-Xiong Liang, Jian-Xu Li
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Purpose In this study, we aimed to compare the radiation-induced hepatic toxicity (RIHT) outcomes of radiotherapy (RT) plus antibodies against programmed cell death protein 1 (anti-PD1) versus RT alone in patients with hepatocellular carcino
Externí odkaz:
https://doaj.org/article/57f25811182f4d709117f3acc54daa7c
Autor:
Jian-Xu Li, Rui-Jun Zhang, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ling He, Mei-Ying Long, Jian-Hong Zhong, Hai-Yan Lu, Hong-Mei Zhou, Bang-De Xiang, Shi-Xiong Liang
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-11 (2023)
Abstract Background The incidence of classic radiation-induced liver disease (cRILD) has been significantly reduced. However, non-classic radiation-induced liver disease (ncRILD) remains a major concern following radiotherapy in patients with hepatoc
Externí odkaz:
https://doaj.org/article/893adf7fbb48498091c2d20ea2dd3dc7
Autor:
Jian-Xu Li, Mei-Ling He, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ying Long, Jian-Hong Zhong, Rui-Jun Zhang, Chun-Feng Liang, Ya-Dan Pang, Jun-Kun He, Qian-Qian Chen, Jin-Xia Weng, Shi-Xiong Liang, Bang-De Xiang
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background For patients with unresectable hepatocellular carcinoma (uHCC), intensity-modulated radiotherapy (IMRT) has become one of the options for clinical local treatment. Immune parameters, including platelet-to-lymphocyte ratio (PLR), n
Externí odkaz:
https://doaj.org/article/3fb320e36d9142d5b555ab321d05a318
Autor:
Jian-Xu Li, Wen-Xiang Deng, Shi-Ting Huang, Xiao-Feng Lin, Mei-Ying Long, Jie Zhang, Ting-Shi Su, Li-Qing Li, Ya-Dan Pang, Chun-Feng Liang, Hong-Mei Zhou, Hai-Yan Lu, Shi-Xiong Liang, Bang-De Xiang
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background The combination of transcatheter arterial chemoembolization (TACE) plus sorafenib prolonged progression-free survival (PFS) and overall survival (OS) than sorafenib or TACE monotherapy for patients with hepatocellular carcinoma (H
Externí odkaz:
https://doaj.org/article/c8e346677fe147e094030ddb3de2cf3b
Autor:
Xiao-zhen Zhang, Su-ping Tao, Shi-xiong Liang, Shu-bin Chen, Fu-shuang Liu, Wei Jiang, Mao-jian Chen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
PurposeCurrently, the relationship between radiation pneumonia (RP) and circulating immune cell in patients with esophageal squamous cell carcinoma (ESCC) remains unclear. This study aimed to explore the relationship between RP and circulating lympho
Externí odkaz:
https://doaj.org/article/b440872dbe0c40d88f09f9156eaafba5
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundRadiation-induced lung injury (RILI) is a severe side effect of radiotherapy for non-small cell lung cancer (NSCLC) ,and one of the major hindrances to improve the efficacy of radiotherapy. Previous studies have confirmed that sodium butyra
Externí odkaz:
https://doaj.org/article/3aaefa1df71d415699b3b3c825c4b35c
Autor:
Ting-Shi Su, Qiu-Hua Liu, Xiao-Fei Zhu, Ping Liang, Shi-Xiong Liang, Lin Lai, Ying Zhou, Yong Huang, Tao Cheng, Le-Qun Li
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In this study, we aimed
Externí odkaz:
https://doaj.org/article/e3d8be23e7654ed2b1dc981f3ca8c55d
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundIn this study, we designed a new (Su’S) target area delineation to protect the normal liver during liver regeneration and prospectively evaluate liver regeneration after radiotherapy, as well as to explore the clinical factors of liver re
Externí odkaz:
https://doaj.org/article/1c67151bf25b4576883334240c6c389c
Autor:
Ting-Shi Su, Hai-Ming Yang, Ying Zhou, Yong Huang, Ping Liang, Tao Cheng, Long Chen, Le-Qun Li, Shi-Xiong Liang
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-6 (2019)
Abstract Background Child-Turcotte-Pugh (CTP) score extensively used to assess hepatic function, predicting postoperative outcome of hepatocellular carcinoma (HCC) patients. Lately, the albumin–bilirubin (ALBI) grade has been identified to be a pre
Externí odkaz:
https://doaj.org/article/f8c18ac0141740c5b8e948cec3f7bc47
Autor:
Ting-Shi Su, Li-Qing Li, Wan-Wan Meng, Yu-Dan Wang, Yi-Tian Chen, Jian-Xu Li, You-Qin Du, Song Qu, Chang Zhao, De-Jia Huang, Shi-Xiong Liang, Le-Qun Li
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Macroscopic vascular invasion (MVI) is a terminal manifestation of hepatocellular carcinoma (HCC) and carries an extremely poor prognosis. In Chinese and Korean HCC guidelines, transarterial chemoembolization (TACE), or/and radiotherapy (
Externí odkaz:
https://doaj.org/article/601bcbda261c4c7b93f8d642d4f54883